Generic versions of biologic drugs could hit the market without human trials and allow the market forces to bring down costs, ...
In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...
NEW YORK, NY – Two prominent biotechnology companies, Vertex Pharmaceuticals and CRISPR Therapeutics, both led by Indian American CEOs, have been named to TIME’s 2025 list of the 100 Most Influential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback